Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price rose 47.4% during trading on Saturday . The company traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares traded hands during mid-day trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Performance
The firm has a market capitalization of C$19.53 million, a PE ratio of -14.00 and a beta of 0.32. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The business’s 50 day simple moving average is C$0.08 and its two-hundred day simple moving average is C$0.06.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- The Significance of Brokerage Rankings in Stock Selection
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Stock Sentiment Analysis: How it Works
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
